ANNALS EXPRESS: Implications for the monitoring of patients with multiple myeloma during treatment with the immunotherapy daratumumab

BackgroundThe novel daratumumab immunotherapy is a human IgG1 kappa antibody targeted against CD38, which is almost universally expressed on myeloma plasma cells. Daratumumab has efficacy in clinic...